Traveling to the American Society of Hematology’s (ASH) annual meeting on December 7–10? We hope to see you at one of our sessions! Save these events to your calendar:
When & Where:
Friday, December 6, from 12–2 p.m. at the Rosen Plaza Hotel in Orlando, Florida.
Each year, ASH joins thousands of leaders around the world who are working to conquer blood diseases. This is a special opportunity for ASH attendees to share insight and chat with physicians practicing in under-resourced countries.
Discussion topics:
Get to know the speakers:
Plan on joining?
To reserve your place, please email Arlene Harris-Buchan.
FYI: The Rosen Plaza Hotel is about a 10-minute walk from the Orange County Convention Center.
When & Where:
Two sessions on Saturday, Dec. 7 | 7:30–9 a.m. & 2–3:30 p.m. |Orange County Convention Center, W315, Level 3
Physicians in lower-income countries are facing challenges related to disease diagnosis, optimal management and monitoring, and providing access to treatment for patients with rare blood diseases. As part of ASH Education program, this session will discuss the obstacles of providing services in low-income countries, and how international partnerships are tackling these barriers.
Peek inside the session:
Dr. Scott Ramsey, Director of Hutchinson Institute for Cancer Outcomes at Fred Hutch, will discuss issues related to introducing generic imatinib, costs, and outcomes for patients, and what the implications are for care as second-generation TKIs become available as generics.
Dr. Hemant Malhotra, Professor of Medicine & Head, Division of Medical Oncology at Birla Cancer Center, will focus on disease characteristics in resource-poor countries and the challenges with monitoring CML.
Dr. Jerald Radich, Faculty Member at Fred Hutch, will discuss the problem of BCR-ABL monitoring in areas where a large number of patients have minimal laboratory facilities for RT-PCR testing. He’ll highlight the innovative ways and means for testing and transporting blood samples.
Pat Garcia-Gonzalez, CEO, The Max Foundation, will highlight the challenges when TKIs and basic diagnostics are unavailable for CML patients living in low-income countries. She’ll also discuss the incredible efforts and partnerships The Max Foundation have made to address these issues.
Learn more about this session here.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Today, Spot On CML is active in 19 countries and, on June 29th, 17 patients were chosen by the treating physicians at Philippine General Hospital to take part in the program. While CML testing is available in the Philippines, it’s prohibitively expensive – placing critical diagnostic information out of reach for many patients.
The Max Foundation CEO recognized for unwavering dedication to global, widespread health equity
Boston, Massachusetts; USA The Max Foundation is proud to announce CEO, Pat Garcia-Gonzalez as the recipient of the National Cancer Institute Global Cancer Medicine Humanitarian Award at the U.S. National Cancer Institute 3rd Annual Symposium on Global Cancer Research held in Boston on 25 March 2015. In the award letter from the National Cancer Institute (NCI), Dr…..
